PACB | tickerfilter.com

Fundamental analysis

20%

Profitability 15%

Dept financing 16%

Liquidity 25%

Performance 25%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

2.37%

1 Month

24.46%

3 Months

-35.21%

6 Months

-5.98%

1 Year

47.86%

2 Year

10.90%

Key data

Stock price

$1.73

P/E Ratio

0.00

DAY RANGE

$1.67 - $1.80

EPS

-$1.82

52 WEEK RANGE

$0.85 - $2.73

52 WEEK CHANGE

$47.86

MARKET CAP

564.567 M

YIELD

N/A

SHARES OUTSTANDING

301.998 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

08-06-2025

BETA

1.19

PUBLIC FLOAT

AVERAGE 10 VOLUME

$5,936,867

AVERAGE 30 VOLUME

$5,975,889

Company detail

CEO: Christian O. Henry
Region: US
Website: pacb.com
Employees: 730
IPO year: 2010

Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. PacBio's Systems conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow.

PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.